Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Irinotecan Hydrochloride API Market Size Growth Rate by Type
1.3.2 Purity ≥ 98 %
1.3.3 Purity ≥ 99 %
1.4 Market Segment by Application
1.4.1 Global Irinotecan Hydrochloride API Market Share by Application (2019-2025)
1.4.2 Irinotecan Hydrochloride Oral
1.4.3 Irinotecan Hydrochloride Injection
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Production and Capacity Analysis
2.1.1 Global Irinotecan Hydrochloride API Production Value 2014-2025
2.1.2 Global Irinotecan Hydrochloride API Production 2014-2025
2.1.3 Global Irinotecan Hydrochloride API Capacity 2014-2025
2.1.4 Global Irinotecan Hydrochloride API Marketing Pricing and Trends
2.2 Key Producers Growth Rate (CAGR) 2019-2025
2.2.1 Global Irinotecan Hydrochloride API Market Size CAGR of Key Regions
2.2.2 Global Irinotecan Hydrochloride API Market Share of Key Regions
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Capacity and Production by Manufacturers
3.1.1 Global Irinotecan Hydrochloride API Capacity by Manufacturers
3.1.2 Global Irinotecan Hydrochloride API Production by Manufacturers
3.2 Revenue by Manufacturers
3.2.1 Irinotecan Hydrochloride API Revenue by Manufacturers (2014-2019)
3.2.2 Irinotecan Hydrochloride API Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Irinotecan Hydrochloride API Market Concentration Ratio (CR5 and HHI)
3.3 Irinotecan Hydrochloride API Price by Manufacturers
3.4 Key Manufacturers Irinotecan Hydrochloride API Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Irinotecan Hydrochloride API Market
3.6 Key Manufacturers Irinotecan Hydrochloride API Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Production and Production Value for Each Type
4.1.1 Purity ≥ 98 % Production and Production Value (2014-2019)
4.1.2 Purity ≥ 99 % Production and Production Value (2014-2019)
4.2 Global Irinotecan Hydrochloride API Production Market Share by Type
4.3 Global Irinotecan Hydrochloride API Production Value Market Share by Type
4.4 Irinotecan Hydrochloride API Ex-factory Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Irinotecan Hydrochloride API Consumption by Application
6 Production by Regions
6.1 Global Irinotecan Hydrochloride API Production (History Data) by Regions 2014-2019
6.2 Global Irinotecan Hydrochloride API Production Value (History Data) by Regions
6.3 North America
6.3.1 North AmericaIrinotecan Hydrochloride API Production Growth Rate 2014-2019
6.3.2 North America Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.3.3 Key Players in North America
6.3.4 North America Irinotecan Hydrochloride API Import & Export
6.4 Europe
6.4.1 Europe Irinotecan Hydrochloride API Production Growth Rate 2014-2019
6.4.2 Europe Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.4.3 Key Players in Europe
6.4.4 Europe Irinotecan Hydrochloride API Import & Export
6.5 China
6.5.1 China Irinotecan Hydrochloride API Production Growth Rate 2014-2019
6.5.2 China Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.5.3 Key Players in China
6.5.4 China Irinotecan Hydrochloride API Import & Export
6.6 Japan
6.6.1 Japan Irinotecan Hydrochloride API Production Growth Rate 2014-2019
6.6.2 Japan Irinotecan Hydrochloride API Production Value Growth Rate 2014-2019
6.6.3 Key Players in Japan
6.6.4 Japan Irinotecan Hydrochloride API Import & Export
7 Irinotecan Hydrochloride API Consumption by Regions
7.1 Global Irinotecan Hydrochloride API Consumption (History Data) by Regions
7.2 North America
7.2.1 North America Irinotecan Hydrochloride API Consumption by Type
7.2.2 North America Irinotecan Hydrochloride API Consumption by Application
7.2.3 North America Irinotecan Hydrochloride API Consumption by Countries
7.2.4 United States
7.2.5 Canada
7.2.6 Mexico
7.3 Europe
7.3.1 Europe Irinotecan Hydrochloride API Consumption by Type
7.3.2 Europe Irinotecan Hydrochloride API Consumption by Application
7.3.3 Europe Irinotecan Hydrochloride API Consumption by Countries
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
7.4 Asia Pacific
7.4.1 Asia Pacific Irinotecan Hydrochloride API Consumption by Type
7.4.2 Asia Pacific Irinotecan Hydrochloride API Consumption by Application
7.4.3 Asia Pacific Irinotecan Hydrochloride API Consumption by Regions
7.4.4 China
7.4.5 Japan
7.4.6 South Korea
7.4.7 India
7.4.8 Australia
7.4.9 Indonesia
7.4.10 Thailand
7.4.11 Malaysia
7.4.12 Philippines
7.4.13 Vietnam
7.5 Central & South America
7.5.1 Central & South America Irinotecan Hydrochloride API Consumption by Type
7.5.2 Central & South America Irinotecan Hydrochloride API Consumption by Application
7.5.3 Central & South America Irinotecan Hydrochloride API Consumption by Countries
7.5.4 Brazil
7.6 Middle East and Africa
7.6.1 Middle East and Africa Irinotecan Hydrochloride API Consumption by Type
7.6.2 Middle East and Africa Irinotecan Hydrochloride API Consumption by Application
7.6.3 Central & South America Irinotecan Hydrochloride API Consumption by Countries
7.6.4 Turkey
7.6.5 GCC Countries
7.6.6 Egypt
7.6.7 South Africa
8 Company Profiles
8.1 Scion Pharm Taiwan
8.1.1 Scion Pharm Taiwan Company Details
8.1.2 Company Description and Business Overview
8.1.3 Production and Revenue of Irinotecan Hydrochloride API
8.1.4 Irinotecan Hydrochloride API Product Introduction
8.1.5 Scion Pharm Taiwan Recent Development
8.2 Acebright
8.2.1 Acebright Company Details
8.2.2 Company Description and Business Overview
8.2.3 Production and Revenue of Irinotecan Hydrochloride API
8.2.4 Irinotecan Hydrochloride API Product Introduction
8.2.5 Acebright Recent Development
8.3 Sai Phytoceuticals
8.3.1 Sai Phytoceuticals Company Details
8.3.2 Company Description and Business Overview
8.3.3 Production and Revenue of Irinotecan Hydrochloride API
8.3.4 Irinotecan Hydrochloride API Product Introduction
8.3.5 Sai Phytoceuticals Recent Development
8.4 Hubei Haosun Pharmaceutical
8.4.1 Hubei Haosun Pharmaceutical Company Details
8.4.2 Company Description and Business Overview
8.4.3 Production and Revenue of Irinotecan Hydrochloride API
8.4.4 Irinotecan Hydrochloride API Product Introduction
8.4.5 Hubei Haosun Pharmaceutical Recent Development
8.5 Arch Pharmalabs
8.5.1 Arch Pharmalabs Company Details
8.5.2 Company Description and Business Overview
8.5.3 Production and Revenue of Irinotecan Hydrochloride API
8.5.4 Irinotecan Hydrochloride API Product Introduction
8.5.5 Arch Pharmalabs Recent Development
8.6 Avra Laboratories
8.6.1 Avra Laboratories Company Details
8.6.2 Company Description and Business Overview
8.6.3 Production and Revenue of Irinotecan Hydrochloride API
8.6.4 Irinotecan Hydrochloride API Product Introduction
8.6.5 Avra Laboratories Recent Development
8.7 Cipla
8.7.1 Cipla Company Details
8.7.2 Company Description and Business Overview
8.7.3 Production and Revenue of Irinotecan Hydrochloride API
8.7.4 Irinotecan Hydrochloride API Product Introduction
8.7.5 Cipla Recent Development
8.8 Lianyungang Jari Pharmaceutical
8.8.1 Lianyungang Jari Pharmaceutical Company Details
8.8.2 Company Description and Business Overview
8.8.3 Production and Revenue of Irinotecan Hydrochloride API
8.8.4 Irinotecan Hydrochloride API Product Introduction
8.8.5 Lianyungang Jari Pharmaceutical Recent Development
8.9 Qilu Pharmaceutial
8.9.1 Qilu Pharmaceutial Company Details
8.9.2 Company Description and Business Overview
8.9.3 Production and Revenue of Irinotecan Hydrochloride API
8.9.4 Irinotecan Hydrochloride API Product Introduction
8.9.5 Qilu Pharmaceutial Recent Development
8.10 Sichuan Xieli Pharmaceutical
8.10.1 Sichuan Xieli Pharmaceutical Company Details
8.10.2 Company Description and Business Overview
8.10.3 Production and Revenue of Irinotecan Hydrochloride API
8.10.4 Irinotecan Hydrochloride API Product Introduction
8.10.5 Sichuan Xieli Pharmaceutical Recent Development
9 Market Forecast: Production Side
9.1 Production and Production Value Forecast
9.1.1 Global Irinotecan Hydrochloride API Capacity, Production Forecast 2019-2025
9.1.2 Global Irinotecan Hydrochloride API Production Value Forecast 2019-2025
9.2 Irinotecan Hydrochloride API Production and Production Value Forecast by Regions
9.2.1 Global Irinotecan Hydrochloride API Production Value Forecast by Regions
9.2.2 Global Irinotecan Hydrochloride API Production Forecast by Regions
9.3 Irinotecan Hydrochloride API Key Producers Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Irinotecan Hydrochloride API Production Forecast by Type
9.4.2 Global Irinotecan Hydrochloride API Production Value Forecast by Type
10 Market Forecast: Consumption Side
10.1 Consumption Forecast by Application
10.2 Irinotecan Hydrochloride API Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Irinotecan Hydrochloride API Consumption Forecast by Countries 2019-2025
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Irinotecan Hydrochloride API Consumption Forecast by Countries 2019-2025
10.4.2 France
10.4.3 UK
10.4.4 Italy
10.4.5 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Irinotecan Hydrochloride API Consumption Forecast by Regions 2019-2025
10.5.2 Japan
10.5.3 South Korea
10.5.4 India
10.5.5 Australia
10.5.6 Indonesia
10.5.7 Thailand
10.5.8 Malaysia
10.5.9 Philippines
10.5.10 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Irinotecan Hydrochloride API Consumption Forecast by Country 2019-2025
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Irinotecan Hydrochloride API Consumption Forecast by Countries 2019-2025
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Irinotecan Hydrochloride API Sales Channels
11.2.2 Irinotecan Hydrochloride API Distributors
11.3 Irinotecan Hydrochloride API Customers
12 Opportunities & Challenges, Threat and Affecting Factors
12.1 Market Opportunities
12.2 Market Challenges
12.3 Porter’s Five Forces Analysis
13 Key Findings
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
【掲載企業】
Scion Pharm Taiwan、Acebright、Sai Phytoceuticals、Hubei Haosun Pharmaceutical、Arch Pharmalabs、Avra Laboratories、Cipla、Lianyungang Jari Pharmaceutical、Qilu Pharmaceutial、Sichuan Xieli Pharmaceutical
【免責事項】
https://www.globalresearch.jp/disclaimer